Try our Advanced Search for more refined results
BionPharma Inc.
-
Misc | Filed: May 14, 2024 | Entered: May 14, 2024 AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Letter
[SEALED] Letter to The Honorable Mitchell S. Goldberg from Megan E. Dellinger regarding -- Answering Letter Brief Regarding Discovery Disputes -- - re 503 Letter,. (Attachments: # 1 Ex. 1, # 2 Ex. 2)(Dellinger, Megan)
-
Misc | Filed: May 10, 2024 | Entered: May 10, 2024 AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Letter
[SEALED] Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding Defendant Bionpharma's Request for an Order Compelling Plaintiff Azurity to Produce Advice-of-Counsel Documents and Privileged Documents It Failed to Log. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Proposed Order)(Phillips, John)
-
Answer | Filed: May 07, 2024 | Entered: May 07, 2024 Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Answer to Counterclaim
ANSWER to 243 Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login